Recombinant human thrombopoietin reduces the risk of acute graft-versus-host-disease and its mechanism
{{output}}
Objective: Acute graft-versus-host disease (aGVHD) is a serious complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). This study aimed to evaluate the effect of recombinant human thrombopoietin (rhTPO) o... ...
